Pathogenesis, diagnosis and treatment of maternally inherited diabetes mellitus with deafness

Chaoqun Wang,Bin Lu,Yifeng Xu,Qingjun Guo,Jiaoyang Zheng
DOI: https://doi.org/10.3760/cma.j.issn.1673-4157.2017.06.013
2017-01-01
International Journal of Endocrinology and Metabolism
Abstract:Maternally inherited diabetes mellitus with deafness (MIDD) is a mitochondrial disorder,accounting for 1% of patients with diabetes mellitus.Insulin secretion dysfunction of β cell caused by tRNALeu (UUR)A3243G mutation may be the main reason of mutation induced diabetes,but the mechanism is not clear.The establishment of EndoC-βH1 cell line provides a way for the study of its mechanism.Heteroplasmy in urinary epithelial cells had the strongest correlation with the phenotype of mitochondrial disease and was considered as the preferred sample to genetic diagnosis and test the heteroplasmy mtDNA.The treatment of MIDD is still focusing on the antioxidant and prevention of diabetic complications.The various clinical phenotypes of A3243G mutations and the heterogeneity of MIDD mutations are still the focus of research,which is of great significance to guide the diagnosis and treatment of MIDD.
What problem does this paper attempt to address?